These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16880571)

  • 21. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
    Lebwohl M; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.
    Swinyer LJ; Decroix J; Langner A; Quiring JN; Blockhuys S
    Cutis; 2007 Jun; 79(6):475-82. PubMed ID: 17713152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study.
    Joly P; Tejedor I; Tetart F; Cailleux HC; Barrel A; De Preville PA; Mion-Mouton N; Gabison G; Baricault S; Tordeur CG; Dore MX; Rossi B; Bourseau-Quetier C; Chamaillard M; Ly S; Chosidow O; Richard-Lallemand MA; Rzeznik JC; Amici JM; Lair G; Bechu S; Benichou J; Thill C; Beylot-Barry M
    J Am Acad Dermatol; 2021 May; 84(5):1278-1284. PubMed ID: 33010323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
    Ozden MG; Tekin NS; Ilter N; Ankarali H
    Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B; Ling MR; Phillips TJ
    J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis.
    Dupuy P; Maurette C; Amoric JC; Chosidow O;
    Br J Dermatol; 2001 May; 144(5):1033-7. PubMed ID: 11359393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole.
    Green CA; Farr PM; Shuster S
    Br J Dermatol; 1987 Feb; 116(2):217-21. PubMed ID: 2950915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of Pityosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique.
    Heng MC; Henderson CL; Barker DC; Haberfelde G
    J Am Acad Dermatol; 1990 Jul; 23(1):82-6. PubMed ID: 1694869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.
    Gold MH; Bridges T; Avakian EV; Plaum S; Fleischer AB; Hardas B
    J Drugs Dermatol; 2012 Apr; 11(4):514-8. PubMed ID: 22453590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
    Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
    Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial.
    Kim TW; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim MB; Song KH; Lee SK; Seo JK; Lee D; Kim BS
    Acta Derm Venereol; 2013 Sep; 93(5):557-61. PubMed ID: 23388687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of dermatosis neglecta, facial seborrheic dermatitis, and corticosteroid-dependent dermatitis in a 21-year-old woman.
    Zhang R; Zhu W
    Am J Clin Dermatol; 2011 Oct; 12(5):347-8. PubMed ID: 21834599
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of seborrhoeic dermatitis of the scalp with a topical solution of urea, lactic acid, and propylene glycol (K301): results of two double-blind, randomised, placebo-controlled studies.
    Emtestam L; Svensson Å; Rensfeldt K
    Mycoses; 2012 Sep; 55(5):393-403. PubMed ID: 21966947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis.
    Langtry JA; Rowland Payne CM; Staughton RC; Stewart JC; Horrobin DF
    Clin Exp Dermatol; 1997 Sep; 22(5):216-9. PubMed ID: 9536541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial.
    Ghodsi SZ; Abbas Z; Abedeni R
    Am J Clin Dermatol; 2015 Oct; 16(5):431-7. PubMed ID: 26016699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis.
    Freeman S; Howard A; Foley P; Rosen R; Wood G; See JA; Gray S
    Australas J Dermatol; 2002 Aug; 43(3):186-9. PubMed ID: 12121395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The red face: seborrheic dermatitis.
    Rebora A; Rongioletti F
    Clin Dermatol; 1993; 11(2):243-51. PubMed ID: 8348438
    [No Abstract]   [Full Text] [Related]  

  • 40. Effective treatment of seborrheic dermatitis using a low dose, oral homeopathic medication consisting of potassium bromide, sodium bromide, nickel sulfate, and sodium chloride in a double-blind, placebo-controlled study.
    Smith SA; Baker AE; Williams JH
    Altern Med Rev; 2002 Feb; 7(1):59-67. PubMed ID: 11896746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.